The medication is administered weekly through injections and works through multiple mechanisms, including: Increasing insulin production to improve glucose absorption during digestion
Wegovy and Ozempic are subcutaneous injection versions, while Rybelsus is an oral tablet
The most common side effects of Wegovy are typically mild gastrointestinal issues, including nausea, vomiting, diarrhea, and constipation
Further, MT-I and MT-II do not possess any anabolic properties or affinity to the same receptors as steroids and are not controlled substances
Metabolic Health Support: Helping regulate insulin resistance and blood sugar levels
Oral Peptide Options Available According to the Direct Meds website, the platform offers: Sublingual Semaglutide: $299 per month according to current platform pricing Sublingual Tirzepatide: $349 per month according to current platform pricing These sublingual formulations are designed for absorption under the tongue, providing a needle-free administration method for patients who prefer not to self-inject